Acalabrutinib-based regimens in frontline or relapsed/refractory higher-risk CLL: pooled analysis of 5 clinical trials
Titel:
Acalabrutinib-based regimens in frontline or relapsed/refractory higher-risk CLL: pooled analysis of 5 clinical trials
Auteur:
Davids, Matthew S. Sharman, Jeff P. Ghia, Paolo Woyach, Jennifer A. Eyre, Toby A. Jurczak, Wojciech Siddiqi, Tanya Miranda, Paulo Shahkarami, Mina Butturini, Anna Emeribe, Ugochinyere Byrd, John C.